Novartis, California

The company is building a new facility in California, its third U.S.-based radioligand therapy production site, and expanding an Indianapolis site for producing isotopes for cancer treatment.

BioMarin

BioMarin executives sought to calm an anxious investor base Wednesday with a public address and pledge to achieve a nearly 50% bump in annual revenue by 2027. But analysts were left wanting.

Syneos Health

Evolvics’ integrated approach, combining qualitative and quantitative insights, will use data- driven evidence to predict how to best deploy omnichannel media campaigns to maximize client impact. This work is fueled by the agency’s mission to ensure that patients, caregivers, and healthcare professionals receive vital, lifesaving information precisely when, where, and how they need it.

As Meta’s new microblogging platform, Threads, is set to feature advertising starting next quarter, this is the perfect time to consider what an all-Meta paid social strategy could look like.

Amgen, California

A broad indication for MariTide could help Amgen secure Medicare coverage for the treatment following FDA approval, CEO Robert Bradway said at Wednesday’s Morgan Stanley Global Healthcare Conference.

Eli Lilly’s weekly insulin injection efsitora alfa secured two late-stage victories on Thursday in a blow to rival Novo Nordisk, which in July failed to secure the FDA’s approval for its basal insulin icodec.